Position in GRFS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$107,771
-$129,447 QoQ
Shares Held
15,222
-40.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#93
of 164 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Compass Wealth Management LLC holds $18,364,693 across 8 Drug Manufacturers - General names. GRFS ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,093 | $7,308,127 | |
| 2 | ABBV |
AbbVie Inc.
|
25,828 | $6,499,357 | |
| 3 | NVS |
Novartis AG
|
12,747 | $1,997,709 | |
| 4 | JNJ |
Johnson & Johnson
|
3,985 | $1,012,070 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,487 | $833,579 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,648 | $325,437 | |
| 7 | AMGN |
Amgen Inc
|
775 | $280,643 | |
| 8 | GRFS |
Grifols SA
This page
|
15,222 | $107,771 |
All Filings in GRFS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,771 | 15,222 | Shares | Sole | 2026-08-10 | |
| 2025-12-31 | $237,218 | 25,371 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $555,947 | 55,818 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $688,088 | 76,116 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $541,184 | 76,116 | Shares | Sole | 2025-04-29 | |
| No filing history on record for this holder in this stock. | ||||||